Observing outcomes of posterior lamellar keratoplasty for eye conditions
Prognosis of Posterior Lamellar Keratoplasty: an Observational Cohort Study
This study looks at how well two types of eye surgeries for conditions like Fuchs' dystrophy and bullous keratopathy work in helping patients see better over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Régional Metz-Thionville Academic / other |
| Locations | 1 site (Metz) |
| Trial ID | NCT06859411 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone posterior lamellar keratoplasty techniques, specifically DSAEK and DMEK, to treat Fuchs' endothelial corneal dystrophy and pseudophakic bullous keratopathy. The study aims to evaluate the prognosis and visual acuity outcomes of these surgical interventions over a specified period. By analyzing data from patients treated at the Metz-Thionville Regional Hospital, researchers will gather insights into the effectiveness and long-term results of these advanced corneal surgeries.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have received posterior lamellar keratoplasty at the Metz-Thionville Regional Hospital between 2012 and 2030.
Not a fit: Patients who refuse to participate in the study will not benefit from the findings.
Why it matters
Potential benefit: If successful, this study could provide valuable information on the effectiveness of posterior lamellar keratoplasty techniques, leading to improved patient outcomes in corneal surgeries.
How similar studies have performed: Other studies have shown promising results with similar posterior lamellar keratoplasty techniques, indicating a potential for success in this observational study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who received a posterior lamellar keratoplasty in Metz-Thionville Regional Hospital between 2012 and 2030 Exclusion Criteria: * patients refusing to take part in the study
Where this trial is running
Metz
- CHR Metz-Thionville Hopital de Mercy — Metz, France (Recruiting)
Study contacts
- Principal investigator: Jean-Marc PERONE, MD — CHR Metz Thionville Hopital de Mercy
- Study coordinator: Arpiné EL NAR, PhD
- Email: projet-recherche-clinique@chr-metz-thionville.fr
- Phone: 0033387557766
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.